Second Opinion: Promising Trends in Cancer Treatment, Part 1

Is the cancer establishment inherently biased against low-tech natural therapies? Dr. Hoffman interviews Ralph Moss, Ph.D. and filmmaker Eric Merola on their new movie, Second Opinion: Did Memorial Sloane Kettering Cancer Center deep-six promising data on Laetrile in the 1970s? Was their motive to suppress unconventional cancer treatments? Why is it important to re-litigate this case four decades later? Dr. Moss weighs in on promising trends in cancer treatment, both mainstream and alternative: ketogenic diet, targeted immunotherapy, hyperthermia, Avemar, Essiac tea, mushrooms, proteolytic enzymes, IV vitamin C.